Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tian, Dongbo
NCT04683406: A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A	Completed	3	750	RoW	ZSP1273 600 mg, Placebo to Oseltamivir, Oseltamivir(oral), Placebo to ZSP1273	Guangdong Raynovent Biotech Co., Ltd	Influenza A	04/23	05/23
NCT04937387: Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma	Completed	3	359	RoW	FF/VI, FF/UMEC/VI, ELLIPTA	GlaxoSmithKline	Asthma	08/24	08/24
TQC2731-Ⅱ-04, NCT06707883: A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease	Recruiting	2	258	RoW	TQC2731 injection, TQC2731 Placebo	Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.	Chronic Obstructive Pulmonary Disease	12/26	09/27